4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3- D]PYRIMIDINDERIVATER OG TILSVARENDE (1H-INDAZOL-3-YL) DERIVATER SOM CGMP- MODULATORER TIL BEHANDLING AF KARDIOVASKULÆRE SYGDOMME

or a pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R2, R4, Ra, and the subscripts m, p, and q are as described herein. The compounds or their pharmaceutically acceptable salts can modulate the body's production of cyclic guanosine monophosphate ("cGMP"), and are gene...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	CHEN, Yi-Heng, GARFUNKLE, Joie, ZHANG, Rui, JI, Gang, MIAO, Shouwu, BERGER, Raphelle, LI, Hong, SMITH, Cameron, J, STELMACH, John, FU, Jianmin, JIANG, Falong, WHITEHEAD, Alan, ZHANG, Yong, RAGHAVAN, Subharekha, LI, Guoqing
Format:	Patent
Sprache:	dan
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!